Isaak Johann, Boesing Maria, Potasso Laura, Lenherr Christoph, Luethi-Corridori Giorgia, Leuppi Joerg D, Leuppi-Taegtmeyer Anne B
University Centre of Internal Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, 4410 Liestal, Switzerland.
Medical Faculty, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland.
J Clin Med. 2023 May 19;12(10):3567. doi: 10.3390/jcm12103567.
Hyponatremia is the most common electrolyte disorder. A proper diagnosis is important for its successful management, especially in profound hyponatremia. The European hyponatremia guidelines point at sodium and osmolality measurement in plasma and urine, and the clinical evaluation of volume status as the minimum diagnostic workup for the diagnosis of hyponatremia. We aimed to determine compliance with guidelines and to investigate possible associations with patient outcomes. In this retrospective study, we analysed the management of 263 patients hospitalised with profound hyponatremia at a Swiss teaching hospital between October 2019 and March 2021. We compared patients with a complete minimum diagnostic workup (D-Group) to patients without (N-Group). A minimum diagnostic workup was performed in 65.5% of patients and 13.7% did not receive any treatment for hyponatremia or an underlying cause. The twelve-month survival did not show statistically significant differences between the groups (HR 1.1, 95%-CI: 0.58-2.12, -value 0.680). The chance of receiving treatment for hyponatremia was higher in the D-group vs. N-Group (91.9% vs. 75.8%, -value < 0.001). A multivariate analysis showed significantly better survival for treated patients compared to not treated (HR 0.37, 95%-CI: 0.17-0.78, -value 0.009). More efforts should be made to ensure treatment of profound hyponatremia in hospitalised patients.
低钠血症是最常见的电解质紊乱。正确诊断对于其成功治疗至关重要,尤其是在严重低钠血症的情况下。欧洲低钠血症指南指出,血浆和尿液中钠和渗透压的测量以及容量状态的临床评估是低钠血症诊断的最低限度诊断检查。我们旨在确定对指南的依从性,并调查与患者预后可能存在的关联。在这项回顾性研究中,我们分析了2019年10月至2021年3月期间在瑞士一家教学医院住院的263例严重低钠血症患者的治疗情况。我们将进行了完整最低限度诊断检查的患者(D组)与未进行该检查的患者(N组)进行了比较。65.5%的患者进行了最低限度诊断检查,13.7%的患者未接受低钠血症或潜在病因的任何治疗。两组之间的12个月生存率没有统计学显著差异(风险比1.1,95%置信区间:0.58 - 2.12,P值0.680)。D组接受低钠血症治疗的机会高于N组(91.9%对75.8%,P值<0.001)。多变量分析显示,接受治疗的患者与未接受治疗的患者相比,生存率显著更高(风险比0.37,95%置信区间:0.17 - 0.78,P值0.009)。应做出更多努力以确保住院患者的严重低钠血症得到治疗。